The Biosurgery Market is estimated to be valued at US$13,887.5 Mn in 2021 and is expected to exhibit a CAGR of 6.9% over the forecast period 2022-2028, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The Biosurgery Market refers to the use of biological or bioengineered materials to facilitate the healing process and to promote tissue regeneration in surgical procedures. This market encompasses a wide range of products, including hemostatic agents, surgical sealants, soft tissue patches, adhesion barriers, and others. These products are used in various surgical applications such as cardiovascular, orthopedic, neurological, and general surgeries, among others. Biosurgery products offer several advantages such as faster wound healing, reduced blood loss, decreased post-operative complications, and improved patient outcomes.

Market Dynamics:
The biosurgery market is driven by two key factors. Firstly, the rising prevalence of chronic diseases such as cardiovascular diseases, orthopedic disorders, and cancer necessitates the need for effective surgical procedures and products for better patient outcomes. The increasing geriatric population and lifestyle changes further contribute to the demand for biosurgery products. Secondly, the growing preference for minimally invasive surgeries is fueling the adoption of biosurgery products. These products enable surgeons to perform precise and targeted procedures with minimal invasiveness, leading to reduced recovery time and improved patient satisfaction. Additionally, technological advancements in biosurgery products, such as the development of advanced hemostatic agents and sealants, further contribute to market growth. Overall, the biosurgery market is expected to witness significant growth due to the increasing demand for effective surgical procedures and the growing preference for minimally invasive surgeries.

Read More : https://www.zupyak.com/p/3874298/t/growing-demand-for-biosurgery-products-drives-the-global-biosurgery-market-to-reach-us-13-887-5-million-by-2022